Safety and efficacy of intravenous thrombolytic therapy in the extended window up to 24 hours: A systematic review and meta‐analysis
Безопасность и эффективность внутривенной тромболитической терапии в расширенном временном окне до 24 часов: систематический обзор и метаанализ
2024-10-29
SCID: 54.1/gfgx3hwd
Discuss with AI
acute ischemic strokeextended therapeutic windowintravenous thrombolytic therapyperfusion imagingsymptomatic intracranial hemorrhage
Figures from the paper
Abstract (AI)
OBJECTIVE: About 25% of patients with acute ischemic stroke (AIS) present within the intravenous thrombolytic (IVT) therapeutic window of <4.5 h. This study is to elucidate the safety and efficacy of IVT in the extended therapeutic window (ETW) in patients with AIS. METHODS: Using PRISMA guidelines, a systematic review was conducted using PubMed, Embase, and Scopus. A rigorous risk of bias assessment was conducted using the RoB2 tool. Rates of excellent and good functional outcome (mRS 0-1 and mRS 0-2) at 90 days, symptomatic intracranial hemorrhage (sICH), and mortality at 90 days were pooled using generalized linear mixed model and compared with controls. Meta-analyses were conducted employing random-effect models with risk ratio (RR) and 95% confidence intervals (CIs). Subgroup analysis was performed to assess the effect of imaging modalities used for patient selection. RESULTS: Eight randomized controlled trials (n = 2221, 59% male) were included. At 90 days IVT showed higher rates of functional recovery: mRS 0-1: RR 1.21 95% CI 1.1-1.34, p < 0.001, and mRS 0-2: RR 1.11 95% CI 1.03-1.18, p = 0.004. Rate of mortality at 90 day was not different between groups: RR 1.17 95% CI 0.93-1.48, p = 0.17. However, the rate of sICH was higher among IVT group: RR 2.93 95% CI 1.53-5.6, p = 0.001. Subgroup analysis showed higher mRS 0-1 among patients who were selected based on perfusion imaging (p < 0.05). INTERPRETATION: The use of IVT in AIS in ETW is beneficial especially with the use of perfusion imaging for patients' selection.
Key Findings
1
A systematic review and meta-analysis of eight randomized controlled trials included 2,221 patients with acute ischemic stroke treated in the extended intravenous thrombolysis window.
2
Extended-window intravenous thrombolysis also improved good functional outcomes at 90 days (mRS 0–2; RR 1.11, 95% CI 1.03–1.18).
3
Extended-window intravenous thrombolysis improved excellent functional outcomes at 90 days (mRS 0–1; RR 1.21, 95% CI 1.10–1.34).
4
Ninety-day mortality did not differ significantly between extended-window thrombolysis and control groups (RR 1.17, 95% CI 0.93–1.48).
5
Symptomatic intracranial hemorrhage was significantly more frequent after extended-window thrombolysis (RR 2.93, 95% CI 1.53–5.60), while perfusion-imaging selection was associated with higher rates of excellent outcomes.
Research Object
Patients with acute ischemic stroke treated with intravenous thrombolytic therapy in the extended therapeutic window up to 24 hours
Research Subject
The safety and efficacy of extended-window intravenous thrombolytic therapy, including functional recovery, symptomatic intracranial hemorrhage, and 90-day mortality, with the influence of perfusion-imaging-based patient selection
Publication Details
Publication Date
2024-10-29
Journal
Publisher
ISSN
Cited by
14
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai2
Cited by3
Efficacy and Safety of Intravenous Thrombolysis in the Extended Time Window for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis2025
Extending the Treatment Window for Intravenous Thrombolysis in Acute Ischemic Stroke: An Updated Systematic Review and Meta-Analysis2026
Safety and efficacy of intravenous tenecteplase in patients with acute ischemic stroke in extended time window: systematic review and meta-analysis2025